Line 414: |
Line 414: |
| ===== II. Platelet abnormalities ===== | | ===== II. Platelet abnormalities ===== |
| | | |
− | a. Thrombocytopenia: ① Diminished or defective platelet production: aplastic anemia, marrow infiltration (carcinoma, leukemia, myelofibrosis, tuberculosis, etc), infections, drugs that act on platelet production (alcohol, thiazide diuretics).② Enhanced platelet destruction: idiopathic thrombocytopenic purpura, drug-induced, thrombotic thrombocytopenic purpura. ③Sequestration of platelets: hypersplenism
| + | #Thrombocytopenia: ① Diminished or defective platelet production: aplastic anemia, marrow infiltration (carcinoma, leukemia, myelofibrosis, tuberculosis, etc), infections, drugs that act on platelet production (alcohol, thiazide diuretics).② Enhanced platelet destruction: idiopathic thrombocytopenic purpura, drug-induced, thrombotic thrombocytopenic purpura. ③Sequestration of platelets: hypersplenism |
− | b. Thrombocytosis: ① Primary: essential thrombocythemia.② Secondary: infections, injury, post-splenectomy chronic myelocytic leukemia, other myeloproliferative disorders (such as polycythemia vera)
| + | #Thrombocytosis: ① Primary: essential thrombocythemia.② Secondary: infections, injury, post-splenectomy chronic myelocytic leukemia, other myeloproliferative disorders (such as polycythemia vera) |
− | c. Functional abnormalities of platelets: ① Congenital: thrombasthenia, giant platelet syndrome (Bernard-Soulier syndrome). ② Acquired: due to drugs, uremia, liver diseases, dysproteinemias
| + | #Functional abnormalities of platelets: ① Congenital: thrombasthenia, giant platelet syndrome (Bernard-Soulier syndrome). ② Acquired: due to drugs, uremia, liver diseases, dysproteinemias |
| | | |
− | III. Coagulation disorders due to coagulation factor deficiencies | + | ===== III. Coagulation disorders due to coagulation factor deficiencies ===== |
− | a. Congenital: hemophilia A (F VIII deficiency), hemophilia B (F IX deficiency),factor XI deficiency (formerly hemophilia C), hypothrombinogenemia, hypofibrinogenemia, von Willebrand’s disease, other coagulation factors deficiency, including deficiency of activatedprotein C inhibitor structural abnormalities
| |
− | b. Acquired: Vitamin K deficiency, severe liver diseases, drugs (dicumarol), disseminated intravascular coagulation (DIC) etc
| |
| | | |
− | IV. Hyperfibrinolysis
| + | #Congenital: hemophilia A (F VIII deficiency), hemophilia B (F IX deficiency),factor XI deficiency (formerly hemophilia C), hypothrombinogenemia, hypofibrinogenemia, von Willebrand’s disease, other coagulation factors deficiency, including deficiency of activatedprotein C inhibitor structural abnormalities |
− | a. Primary: Congenital deficiency of α2 antiplasmin, clinical use of urokinase, liver diseases, liberation of tissue plasminogen activator into the circulation
| + | #Acquired: Vitamin K deficiency, severe liver diseases, drugs (dicumarol), disseminated intravascular coagulation (DIC) etc |
− | b. Secondary: DIC
| |
| | | |
| + | ===== IV. Hyperfibrinolysis ===== |
| + | |
| + | #Primary: Congenital deficiency of α2 antiplasmin, clinical use of urokinase, liver diseases, liberation of tissue plasminogen activator into the circulation |
| + | #Secondary: DIC |
| + | |
| + | ==== Causes of Bleeding ==== |
| | | |
| When normal hemostatic mechanisms fail, major hemorrhage may follow minor trauma or may appear to arise spontaneously. Biomedicine observes spontaneous bleeding primarily from either the rectum or from the naso-pharyngeal cavity. | | When normal hemostatic mechanisms fail, major hemorrhage may follow minor trauma or may appear to arise spontaneously. Biomedicine observes spontaneous bleeding primarily from either the rectum or from the naso-pharyngeal cavity. |
| | | |
− | A. Causes of bleeding from the mouth | + | ===== A.Causes of bleeding from the mouth ===== |
| | | |
| i) Common causes of bleeding from the mouth include: | | i) Common causes of bleeding from the mouth include: |